Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-282740

Chief Medical Officer sold 41,845 shares at an average $21.08 ($882,203)

  • Chief Medical Officer acquired 36,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Janku Filip · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-23 Exercise or conversion : show line 1 in the form 10b5-1 +6,000 $7.56 $45,360 71,837 D
2026-06-23 Sale : show line 2 in the form 10b5-1 −11,845 $20.22 $239,522 59,992 D
2026-06-24 Exercise or conversion : show line 3 in the form 10b5-1 +30,000 $7.56 $226,800 89,992 D
2026-06-24 Sale : show line 4 in the form 10b5-1 −30,000 $21.42 $642,681 59,992 D
Open-market sales · 41,845 sh · avg $21.08 · $882,203

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-23 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −6,000 96,000 D
2026-06-24 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −30,000 66,000 D
Loading xslF345X06/ownership.xml…